Call for Risk/benefit Study of Gene Therapy
Nature. 1994 Dec 22/29; 372(6508): 716.
Showing items related by title, author, creator and subject.
Calculating risk/benefit in X-linked severe combined immune defieciency disorder (X-SCID) gene therapy trials: the task of ethical evaluation Swazo, Norman K. (2006-10)In response to adverse events in retroviral gene therapy clinical trials conducted in France to correct for X-linked severe combined immune deficiency disorder (X-SCID), an advisory committee of the Food and Drug Administration ...